𝔖 Bobbio Scriptorium

✦ LIBER ✦

Relapse After Allogeneic Stem Cell Transplantation (SCT): Retransplantation Does Not Improve Outcome in Comparison to Supportive Care and Chemotherapy

✍ Scribed by R. Arnold; P. Hemmati; T. Terwey; L. Voung; P. le Coutre; B. Doerken; G. Massenkeil

Book ID: 116282417
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 52 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.481

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects Of Changes In Conditioning Regim

Effects Of Changes In Conditioning Regimen And Supportive Care On Outcomes In Patients With Acute Myeloid Leukemia (AML) After Allogeneic Stem Cell Transplantation (Allo-SCT)

✍ V. Abello; C. Rosales; E. Pedraza; A. Linares; H. Esguerra; M. Rosales; J. Figue 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

High-dose busulfan, cyclophosphamide, an

High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia

✍ Farag, S S; Bolwell, B J; Elder, P J; Kalaycio, M; Lin, T; Pohlman, B; Penza, S; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB